Skip to main content
Clinical Trials/NCT00257842
NCT00257842
Terminated
Not Applicable

Randomized Controlled Trial of Biofeedback Therapy for Dyssynergic Defecation

Augusta University1 site in 1 countryNovember 23, 2005
ConditionsDyssynergia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dyssynergia
Sponsor
Augusta University
Locations
1
Status
Terminated
Last Updated
11 years ago

Overview

Brief Summary

Constipation is a common disorder and current treatments are unsatisfactory. Biofeedback may help patients with constipation and dyssynergic defecation, but its efficacy is unproven and whether this is due to behavioral modification or excessive attention is unknown. Methods: In a prospective randomized trial, the investigators investigated the efficacy of Biofeedback (manometric- assisted anal relaxation, muscle coordination and simulated defecation training), with either sham feedback therapy (Sham) or standard therapy (diet, exercise, laxatives; Standard) in 77 subjects (69 women) with dyssynergic defecation. Primary outcome measures included presence of dyssynergia, balloon expulsion time, number of complete spontaneous bowel movements (CSBM), and global bowel satisfaction. Data analyzed per protocol.

Registry
clinicaltrials.gov
Start Date
November 23, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Satish Rao

pi

Augusta University

Eligibility Criteria

Inclusion Criteria

  • Patients were included if they fulfilled Rome II criteria for functional constipation, and during attempted defecation demonstrated a dyssynergic pattern of defecation, and either had prolonged difficulty with expelling a simulated stool (\> 1 minute) or prolonged delay (\> 20% marker retention) in colonic transit.

Exclusion Criteria

  • They were required to have no evidence of structural or metabolic diseases that could cause constipation, as assessed by colonoscopy/barium enema and routine hematological, biochemical and thyroid function tests. Patients taking drugs known to be constipating, for example opioids were either excluded or were asked to discontinue the drug prior to enrollment. Other exclusion criteria included: severe cardiac or renal disease, previous gastrointestinal, spinal or pelvic surgery except cholecystectomy, hysterectomy or appendectomy, neurologic diseases such as multiple sclerosis, stroke or spinal injury, impaired cognizance (mini-mental score \< 15), legal blindness, pregnancy, rectal prolapse, anal fissure, and alternating constipation and diarrhea.

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials